ChemoCentryx, Inc. Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Offer Letter between the Company and Rita I. Jain, dated October 5, 2021 (Filed With SEC on October 12, 2021)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 1, 2021)
- Commercial Manufacturing Agreement, dated as of August 26, 2020, by and between the Registrant and Hovione LLC (Filed With SEC on November 9, 2020)
- Product Agreement, dated as of May 8, 2020, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on August 10, 2020)
- Right to Invest Agreement, dated as of January 8, 2020, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on May 11, 2020)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2020)
- Letter Agreement dated as of June 6, 2018 between the Registrant and Vifor (International) Ltd. regarding Grant of Rights to CCX140 in China (Filed With SEC on August 9, 2018)
- Letter Agreement dated as of June 6, 2018 between the Registrant and Vifor (International) Ltd. regarding Grant of Rights to CCX168 in China (Filed With SEC on August 9, 2018)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FORCONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on May 10, 2017)
- 1 of 58 (Filed With SEC on December 20, 2007)
- CHEMOCENTRYX, INC. AMENDED AND RESTATED (Filed With SEC on November 9, 2007)
